ZEB1-activated LINC01123 Accelerates the Malignancy in Lung Adenocarcinoma Through NOTCH Signaling Pathway

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2020 Nov 16

PMID 33191397

Citations 21

Authors

Miao Zhang

Yaguang Han

Yi Zheng

Yan Zhang

Xin Zhao

Zhenlin Gao

Xinyan Liu

Affiliations

Soon will be listed here.

Abstract

Growing incidence of lung adenocarcinoma (LUAD) has been detected recently. Multiple long non-coding RNAs (lncRNAs) have been proven as tumor facilitators or inhibitors by extensive works. Present study concentrated on characterizing the potential role of LINC01123 in LUAD. We explored the differential expression of LINC01123 through qRT-PCR and found the amplification of LINC01123 in LUAD cell lines. It was ascertained that LINC01123 was definitely responsible for the malignant processes of LUAD cells. Further, we validated the ceRNA network of LINC01123/miR-449b-5p/NOTCH1 in LUAD via mechanical experiments. As a transcriptional factor related to epithelial mesenchymal transition (EMT), ZEB1 was responsible for the transcriptional activation of both LINC01123 and NOTCH1. The involvement of NOTCH signaling in LUAD was interrogated through evaluating functional changes after treating with FLI-06 (NOTCH pathway suppressor). It showed that FLI-06-caused NOTCH signaling inactivation suppressed malignant functions in LUAD cells. Additionally, LINC01123 facilitated NOTCH1-dependent NOTCH signaling activation. Rescue experiments probed the modulatory function of LINC01123/miR-449b-5p/NOTCH1 in LUAD cellular processes. Altogether, ZEB1-activated LINC01123 accelerates the malignancy in LUAD through miR-449b-5p/NOTCH1 axis-mediated NOTCH signaling pathway, while NOTCH1 boosts ZEB1 in return. These observations suggest the huge potential of LINC01123 as a new target for LUAD therapy.

Citing Articles

[GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway].

Huo Y, Xu X, Ma X, Feng Y Zhongguo Fei Ai Za Zhi. 2024; 27(10):735-744.

PMID: 39631830 PMC: 11629005. DOI: 10.3779/j.issn.1009-3419.2024.101.27.

TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway.

Wang G, Wu Y, Su Y, Qu N, Chen B, Zhou D J Transl Med. 2024; 22(1):745.

PMID: 39113057 PMC: 11304905. DOI: 10.1186/s12967-024-05536-6.

Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma.

Wei H, Zhang S, Lin X, Fang R, Li L Front Oncol. 2024; 14:1411672.

PMID: 38912059 PMC: 11190727. DOI: 10.3389/fonc.2024.1411672.

CircRNA LDLR promotes proliferation and aerobic glycolysis of gastric cancer cells by targeting CHD1 with miR-449b-5p.

Zeng F, Zhao J, Tong M, He W, Li N, Fan Y Turk J Biol. 2024; 48(1):46-58.

PMID: 38665782 PMC: 11042865. DOI: 10.55730/1300-0152.2681.

The Notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials.

Zhao F, He Y, Zhao Z, He J, Huang H, Ai K Front Immunol. 2023; 14:1272133.

PMID: 38022508 PMC: 10643158. DOI: 10.3389/fimmu.2023.1272133.

References

Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng Y . A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27. Cell Death Dis. 2015; 6:e1858. PMC: 4558496. DOI: 10.1038/cddis.2015.203. View

He Y, Deng F, Zhao S, Zhong S, Zhao J, Wang D . Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1. Epigenomics. 2019; 11(9):1021-1036. DOI: 10.2217/epi-2019-0072. View

Hung C, Wang L, Yu Y, Chen H, Srivastava S, Petrovics G . A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014; 111(52):18697-702. PMC: 4284533. DOI: 10.1073/pnas.1415669112. View

Cheng L, Shi X, Huo D, Zhao Y, Zhang H . MiR-449b-5p regulates cell proliferation, migration and radioresistance in cervical cancer by interacting with the transcription suppressor FOXP1. Eur J Pharmacol. 2019; 856:172399. DOI: 10.1016/j.ejphar.2019.05.028. View

Gupta R, Shah N, Wang K, Kim J, Horlings H, Wong D . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464(7291):1071-6. PMC: 3049919. DOI: 10.1038/nature08975. View

Xiong Y, Liu Z, Li Z, Wang S, Shen N, Xin Y . Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1. Int J Oncol. 2019; 55(5):1125-1136. DOI: 10.3892/ijo.2019.4869. View

Tsai M, Spitale R, Chang H . Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011; 71(1):3-7. PMC: 3057914. DOI: 10.1158/0008-5472.CAN-10-2483. View

Imielinski M, Berger A, Hammerman P, Hernandez B, Pugh T, Hodis E . Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012; 150(6):1107-20. PMC: 3557932. DOI: 10.1016/j.cell.2012.08.029. View

Tamagnone L, Zacchigna S, Rehman M . Taming the Notch Transcriptional Regulator for Cancer Therapy. Molecules. 2018; 23(2). PMC: 6017063. DOI: 10.3390/molecules23020431. View

10.

Peng L, Jiang B, Yuan X, Qiu Y, Peng J, Huang Y . Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma. Cancer Res. 2018; 79(3):572-584. DOI: 10.1158/0008-5472.CAN-18-0367. View

11.

Travis W, Brambilla E, Nicholson A, Yatabe Y, Austin J, Beasley M . The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10(9):1243-1260. DOI: 10.1097/JTO.0000000000000630. View

12.

Kretz M, Siprashvili Z, Chu C, Webster D, Zehnder A, Qu K . Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2012; 493(7431):231-5. PMC: 3674581. DOI: 10.1038/nature11661. View

13.

Liang R, Xiao G, Wang M, Li X, Li Y, Hui Z . SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma. Biomed Pharmacother. 2018; 107:1434-1446. DOI: 10.1016/j.biopha.2018.08.099. View

14.

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

15.

Qu R, Chen X, Zhang C . LncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer. Biochem Biophys Res Commun. 2018; 507(1-4):450-456. DOI: 10.1016/j.bbrc.2018.11.059. View

16.

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

17.

Morigele M, Shao Z, Zhang Z, Kaige M, Zhang Y, Qiang W . TGF-β1 induces a nucleus pulposus-like phenotype in Notch 1 knockdown rabbit bone marrow mesenchymal stem cells. Cell Biol Int. 2013; 37(8):820-5. DOI: 10.1002/cbin.10109. View

18.

Copur M, Crockett D, Gauchan D, Ramaekers R, Mleczko K . Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy. J Clin Oncol. 2018; 36(19):2006. DOI: 10.1200/JCO.2018.78.8240. View

19.

Yin W, Shi L, Mao Y . MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma. J Biochem. 2019; 166(5):433-440. DOI: 10.1093/jb/mvz057. View

20.

Diao P, Song Y, Ge H, Wu Y, Li J, Zhang W . Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma. J Cell Biochem. 2018; 120(6):10010-10020. DOI: 10.1002/jcb.28284. View